相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter
Amar Bahadur Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
IMPROVE-IT and genetics reaffirm the causal role of LDL in Cardiovascular Disease Discussion
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2015)
Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy
Yoshinori Osaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
Erin A. Bohula et al.
CIRCULATION (2015)
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes et al.
EUROPEAN HEART JOURNAL (2015)
Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
Paul D. Thompson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Acyl-CoA Metabolism and Partitioning
Trisha J. Grevengoed et al.
ANNUAL REVIEW OF NUTRITION, VOL 34 (2014)
Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol-Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus
Maria J. Gutierrez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies
Dhiaa A. Taha et al.
TRANSLATIONAL RESEARCH (2014)
Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
Warner M. Mampuya et al.
AMERICAN HEART JOURNAL (2013)
The Role of Early LDL Lowering to Prevent the Onset of Atherosclerotic Disease
Brian A. Ference et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Statin Therapy for Primary Prevention of Cardiovascular Disease
Fiona C. Taylor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism
Stephen L. Pinkosky et al.
JOURNAL OF LIPID RESEARCH (2013)
Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia
Christie M. Ballantyne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
AMP-activated protein kinase: new regulation, new roles?
David Carling et al.
BIOCHEMICAL JOURNAL (2012)
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
D. Grahame Hardie et al.
CHEMISTRY & BIOLOGY (2012)
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
Sandra Galic et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients
Patricia Maningat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
AMPK inhibition in health and disease
Benoit Viollet et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Nicolas Dzamko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice
Qiong Wang et al.
JOURNAL OF LIPID RESEARCH (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
The Contribution of the Framingham Heart Study to the Prevention of Cardiovascular Disease: A Global Perspective
Shanthi Mendis
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
AMPK and the biochemistry of exercise: implications for human health and disease
Erik A. Richter et al.
BIOCHEMICAL JOURNAL (2009)
Abrogation of Hepatic ATP-Citrate Lyase Protects Against Fatty Liver and Ameliorates Hyperglycemia in Leptin Receptor-Deficient Mice
Qiong Wang et al.
HEPATOLOGY (2009)
A novel direct homogeneous assay for ATP citrate lyase
Zhengping Ma et al.
JOURNAL OF LIPID RESEARCH (2009)
Possible Mechanisms Underlying Statin-Induced Skeletal Muscle Toxicity in L6 Fibroblasts and in Rats
Mai Itagaki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
AMPK: a metabolic gauge regulating whole-body energy homeostasis
Ricardo Lage et al.
TRENDS IN MOLECULAR MEDICINE (2008)
AMP-activated protein kinase in the heart - Role during health and disease
Michael Arad et al.
CIRCULATION RESEARCH (2007)
The fatty acid transport protein (FATP) family: Very long chain acyl-CoA synthetases or solute carriers?
Zhenzhen Jia et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein
S Matzno et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Molecular clues into the pathogenesis of statin-mediated muscle toxicity
SK Baker
MUSCLE & NERVE (2005)
Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice
J Zhou et al.
CIRCULATION (2005)
Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: Identification of a novel variant of isoform 6
CG Van Horn et al.
BIOCHEMISTRY (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors
H Li et al.
ANALYTICAL BIOCHEMISTRY (2005)
Safety of statins - Focus on clinical pharmacokinetics and drug interactions
S Bellosta et al.
CIRCULATION (2004)
Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone
TE Johnson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid : CoA ligases of human liver
DA Vessey et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2004)
Characterization of the acyl-CoA synthetase activity of purified murine fatty acid transport protein 1
AM Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SREBPs: Transcriptional mediators of lipid homeostasis
JD Horton et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2002)
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in apoE-deficient mice
J Zhou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Expression and characterization of recombinant rat acyl-CoA synthetases 1, 4, and 5 - Selective inhibition by triacsin C and thiazolidinediones
JH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
